A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Class I Major Histocompatibility Complex (MHC) molecules are crucial for adaptive immunity, presenting endogenous peptides to T cells.
• These heterodimeric molecules consist of a heavy chain and a light chain, beta 2-microglobulin (β2m).
• Understanding MHC assembly and peptide binding is vital for immunology and vaccine development.

Purpose of the Study:

• To synthesize a gene encoding a single-chain, soluble class I MHC molecule.
• To investigate the functional properties of this engineered molecule, including secretion, stability, and peptide binding.
• To explore the implications for MHC assembly pathways and potential applications.

Main Methods:

• Gene synthesis encoding a single-chain H-2Dd MHC molecule with a peptide spacer linking β2m to the heavy chain.
• Expression of the chimeric protein in transfected L cells.
• Assessment of protein secretion, thermostability, and peptide-binding capacity using T-cell hybridoma stimulation assays.

Main Results:

• The synthesized single-chain MHC molecule was efficiently secreted from transfected cells and exhibited thermostability.
• The chimeric protein, when loaded with an antigenic peptide, successfully stimulated an H-2Dd-restricted antigen-specific T-cell hybridoma.
• Functional peptide binding occurred without complete dissociation of β2m, suggesting a non-obligate role for heavy chain/peptide intermediates.

Conclusions:

• Single-chain class I MHC molecules can be functionally engineered, retaining essential immunological properties.
• The findings challenge traditional models of MHC assembly, indicating that complete β2m dissociation is not always required for peptide binding.
• Engineered single-chain MHC molecules offer promising avenues for structural biology, vaccine design, and targeted drug delivery systems.